Co-Authors
This is a "connection" page, showing publications co-authored by Vito Lampasona and Cristina Brigatti.
Connection Strength
0.634
-
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020 12 01; 130(12):6366-6378.
Score: 0.229
-
Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. 2020 12; 63(12):2548-2558.
Score: 0.227
-
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia. Biology (Basel). 2021 Aug 05; 10(8).
Score: 0.060
-
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021 05 11; 12(1):2670.
Score: 0.059
-
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. J Clin Endocrinol Metab. 2021 04 23; 106(5):1472-1481.
Score: 0.059